HIV-1 Escape from Small-Molecule Antagonism of Vif
Open Access
- 26 February 2019
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 10 (1) , e00144-19
Abstract
Although antiretroviral therapy can suppress HIV-1 replication effectively, virus reservoirs persist in infected individuals and virus replication rapidly rebounds if therapy is interrupted. Currently, there is a need for therapeutic approaches that eliminate, reduce, or control persistent viral reservoirs if a cure is to be realized. This work focuses on the preclinical development of novel, small-molecule inhibitors of the HIV-1 Vif protein. Vif inhibitors represent a new class of antiretroviral drugs that may expand treatment options to more effectively suppress virus replication or to drive HIV-1 reservoirs to a nonfunctional state by harnessing the activity of the DNA-editing cytidine deaminase A3G, a potent, intrinsic restriction factor expressed in macrophage and CD4 + T cells. In this study, we derived inhibitor escape variants to characterize the mechanism by which these novel agents inhibit virus replication and to provide evidence for target validation.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI096109)
- HHS | NIH | National Institute of Mental Health (MH100942, MH093306)
This publication has 38 references indexed in Scilit:
- Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Targeting the Interaction between Vif and ElonginCJournal of Virology, 2012
- The SOCS-Box of HIV-1 Vif Interacts with ElonginBC by Induced-Folding to Recruit Its Cul5-Containing Ubiquitin Ligase ComplexPLOS Pathogens, 2010
- APOBEC proteins and intrinsic resistance to HIV-1 infectionPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Small-molecule inhibition of HIV-1 VifNature Biotechnology, 2008
- Structural Insight into the Human Immunodeficiency Virus Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase AssemblyJournal of Virology, 2008
- Evolution of HIV-1 Isolates that Use a Novel Vif-Independent Mechanism to Resist Restriction by Human APOBEC3GCurrent Biology, 2008
- Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3GNucleic Acids Research, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002